...
首页> 外文期刊>Journal of Pharmacology and Pharmacotherapeutics >A prospective study to compare the effects of pre, intra and post operative steroid (dexamethasone sodium phosphate) on post tonsillectomy morbidity
【24h】

A prospective study to compare the effects of pre, intra and post operative steroid (dexamethasone sodium phosphate) on post tonsillectomy morbidity

机译:一项前瞻性研究,比较术前,术中和术后类固醇(地塞米松磷酸钠)对扁桃体切除术后并发症的影响

获取原文

摘要

Objective:To determine the effectiveness of dexamethasone on post tonsillectomy morbidities in patients with chronic tonsillitis.Materials and Methods:In this randomized double-blind study, 100 patients who underwent tonsillectomy were enrolled and were randomly allocated into control or dexamethasone group (pre operative, intra operative and post operative groups). Patients were assessed for pain nausea, vomiting and oral intake in the post operative period at 24 h.Results:Patients treated with dexamethasone particularly in the pre and intra operative groups (Group B, Group C) showed a general trend towards lower pain score than post operative group (Group D). The scores were about 1.72±0.84 and 2.20±1.19 in Groups B and C respectively, and 2.64±0.99 in Group D. Overall pain score was found to be more in the control Group A about 4.84±1.21 at 6 h post operatively and showed similar trend for next 24 h. Total number of patients with nausea was significantly high about 84% in control group compared to dexamethasone groups (Group B, C and D) about 20%, 8% and 24% respectively and also incidence of vomiting episodes showed a similar trend. Oral intake was significantly delayed in control group (6.16 ±1.52), P < 0.001 than dexamethasone group. Pre operative and intra operative groups showed early intake (3.68±0.68) and (3.60±1.12) respectively than the postoperative group (5.08±0.95).Conclusions:A single intravenous dose of dexamethasone, given following induction of anaesthesia and at the time of surgery, provided prolonged analgesia, reduced nausea and vomiting and resulted in earlier oral intake.
机译:目的:确定地塞米松对慢性扁桃体炎患者扁桃体切除术后发病的有效性。材料与方法:本随机双盲研究纳入了100例行扁桃体切除术的患者,随机分为对照组或地塞米松组(术前,术中和术后组)。评估患者术后24小时的疼痛恶心,呕吐和口服摄入量。结果:地塞米松治疗的患者,特别是术前和术中组(B组,C组)的总体趋势是疼痛评分低于术后组(D组)。 B组和C组的得分分别约为1.72±0.84和2.20±1.19,D组的得分为2.64±0.99。术后6小时,对照组A的总体疼痛得分约为4.84±1.21,表现为接下来24小时的趋势相似。与地塞米松组(B,C和D组)分别约20%,8%和24%相比,对照组中的恶心患者总数显着较高,约为84%,并且呕吐发作的发生率也显示出相似的趋势。对照组的口服摄入明显延迟(6.16±1.52),与地塞米松组相比,P <0.001。术前和术中组分别较术后组(5.08±0.95)早摄入(3.68±0.68)和(3.60±1.12)。结论:麻醉诱导后和麻醉后给予地塞米松单剂量。手术,可以延长镇痛时间,减少恶心和呕吐,并可以更早地口服。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号